METHODS AND SYSTEMS OF USING EXOSOMES FOR DETERMINING PHENOTYPES

Patent №

US 7,897,356

Granted

2011-03-01

Filed 2009

Owner

CARIS MPI, INC.

+2 more

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

12591226

Exosomes can be used for detecting biomarkers for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, for example, the stage or progression of a disease. Cell-of-origin exosomes can be used in profiling of physiological states or determining phenotypes. Biomarkers or markers from cell-of-origin specific exosomes can be used to determine treatment regimens for diseases, conditions, disease stages, and stages of a condition, and can also be used to determine treatment efficacy. Markers from cell-of-origin specific exosomes can also be used to identify conditions of diseases of unknown origin.

PlanningG01N 33/5758C12Q 1/6811C12Q 1/6886G01N 33/5023G01N 33/54326G01N 33/575G01N 33/57535G01N 33/57555+4 more

AI classification

Planning1.00
Machine learning0.37
Knowledge representation0.00
Vision0.00
Natural language0.00
AI hardware0.00
Evolutionary computation0.00
Speech0.00

Ownership

CARIS MPI, INC.

assignment · 245400420

CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS, S.A.R.L.

assignment · 276580837

CARIS LIFE SCIENCES SWITZERLAND HOLDINGS GMBH

namechg · 339830910

Assignors

KLASS, MICHAEL, KUSLICH, CHRISTINE, POSTE, GEORGE

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC